ATLASMirum Pharmaceuticals (MIRM) earnings date: Nov 3, 2026
Mirum Pharmaceuticals (MIRM) reports earnings for the quarter ended Sep 30, 2026 on Tue, Nov 3, 2026, after the close. Analysts expect EPS of -$0.53.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MIRM
| Last price | $85.00 (-1.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±2.7% |
| Earnings beat history | Beat the EPS estimate in 0 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Mirum Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Mirum Pharmaceuticals reports on Nov 3, 2026. One email the day before, with ATLAS’s read on Mirum Pharmaceuticals. You can switch it off at any time.
Alert me before MIRM reportsFree to start. Creating an account takes under a minute.
MIRM earnings at a glance
| Next report (confirmed) | Tue, Nov 3, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.53 |
| Last report | Aug 5, 2026 · Miss |
| Beat rate (last 4 reports) | 0 of 4 (0%) |
| Average EPS surprise | -131.4% |
| Average move around a report | ±7.3% (last 4) |
| Sector | Healthcare · Biotechnology |
Mirum Pharmaceuticals earnings history: last 4 reports
Mirum Pharmaceuticals last reported on Aug 5, 2026: EPS of -$0.80 against an estimate of -$0.75 (-6.7% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 5, 2026 | -$0.75 | -$0.80 | -6.7% | Miss | -9.8% |
| May 6, 2026 | -$0.35 | -$1.08 | -208.6% | Miss | -2.7% |
| Feb 25, 2026 | $0.06 | -$0.12 | -300.0% | Miss | -14.2% |
| Jan 17, 2026 | $0.38 | $0.34 | -10.5% | Miss | +2.4% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MIRM
See the fair value, the probability range and the earnings history of Mirum Pharmaceuticals on its ATLAS page.
Mirum Pharmaceuticals (MIRM) stock analysisPlans from €3.99 a month.
Mirum Pharmaceuticals earnings: frequently asked questions
When does Mirum Pharmaceuticals (MIRM) report earnings?
Mirum Pharmaceuticals is scheduled to report on Tuesday, November 3, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MIRM?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.53 per share (USD). Estimates can change before the report.
How often does MIRM beat earnings estimates?
Of its last 4 reports with a recorded result, Mirum Pharmaceuticals beat the EPS estimate 0 times; the average surprise was -131.4%. Past results do not predict the next one.
How much does MIRM move around earnings?
Over its last 4 reports the stock moved an average of 7.3% (absolute, from the close before the report day to the close after it), and finished higher 1 of 4 times.
Did Mirum Pharmaceuticals beat earnings estimates last quarter?
Mirum Pharmaceuticals last reported on Aug 5, 2026: EPS of -$0.80 against an estimate of -$0.75 (-6.7% surprise), a miss.
How much does MIRM usually move in a day?
On a normal trading day the ATLAS model puts MIRM’s one-day range at about ±2.7%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Tue, Nov 3, 2026
Educational information, not investment advice. Disclaimer